Amgen Inc.
Chimeric receptors and methods of use thereof
Last updated:
Abstract:
Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.
Status:
Grant
Type:
Utility
Filling date:
31 Mar 2017
Issue date:
24 Mar 2020